METTL14 modulates glycolysis to inhibit colorectal tumorigenesis in p53‐wild‐type cells
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
METTL14 modulates glycolysis to inhibit colorectal tumorigenesis in p53‐wild‐type cells ; day:16 ; month:02 ; year:2023 ; extent:21
EMBO reports / European Molecular Biology Organization ; (16.02.2023) (gesamt 21)
- Urheber
-
Hou, Yichao
Zhang, Xintian
Yao, Han
Hou, Lidan
Zhang, Qingwei
Tao, Enwei
Zhu, Xiaoqiang
Jiang, Shanshan
Ren, Yimeng
Hong, Xialu
Lu, Shiyuan
Leng, Xiaoxu
Xie, Yile
Gao, Yaqi
Liang, Yu
Zhong, Ting
Long, Bohan
Fang, Jing‐Yuan
Meng, Xiangjun
- DOI
-
10.15252/embr.202256325
- URN
-
urn:nbn:de:101:1-2023021614321980443250
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
2025-08-14T10:52:08+0200
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hou, Yichao
- Zhang, Xintian
- Yao, Han
- Hou, Lidan
- Zhang, Qingwei
- Tao, Enwei
- Zhu, Xiaoqiang
- Jiang, Shanshan
- Ren, Yimeng
- Hong, Xialu
- Lu, Shiyuan
- Leng, Xiaoxu
- Xie, Yile
- Gao, Yaqi
- Liang, Yu
- Zhong, Ting
- Long, Bohan
- Fang, Jing‐Yuan
- Meng, Xiangjun
Ähnliche Objekte (12)
Oroxylin A promotes PTEN-mediated negative regulation of MDM2 transcription via SIRT3-mediated deacetylation to stabilize p53 and inhibit glycolysis in wt-p53 cancer cells
Skp2 modulates proliferation, senescence and tumorigenesis of glioma
PRMT1-mediated PGK1 arginine methylation promotes colorectal cancer glycolysis and tumorigenesis
The TRPM7 channel reprograms cellular glycolysis to drive tumorigenesis and angiogenesis
Correction to: Oroxylin A promotes PTEN-mediated negative regulation of MDM2 transcription via SIRT3-mediated deacetylation to stabilize p53 and inhibit glycolysis in wt-p53 cancer cells
SIX1 amplification modulates stemness and tumorigenesis in breast cancer
UBR7 inhibits HCC tumorigenesis by targeting Keap1/Nrf2/Bach1/HK2 and glycolysis
Monocytes reprogrammed by tumor microparticle vaccine inhibit tumorigenesis and tumor development
Wip1 and p53 contribute to HTLV-1 Tax-induced tumorigenesis
AKT1 phosphorylation of cytoplasmic ME2 induces a metabolic switch to glycolysis for tumorigenesis
ZFP64 drives glycolysis-mediated stem cell-like properties and tumorigenesis in breast cancer
FKBP4 promotes glycolysis and hepatocellular carcinoma progression via p53/HK2 axis
Oroxylin A promotes PTEN-mediated negative regulation of MDM2 transcription via SIRT3-mediated deacetylation to stabilize p53 and inhibit glycolysis in wt-p53 cancer cells
Skp2 modulates proliferation, senescence and tumorigenesis of glioma
PRMT1-mediated PGK1 arginine methylation promotes colorectal cancer glycolysis and tumorigenesis
The TRPM7 channel reprograms cellular glycolysis to drive tumorigenesis and angiogenesis
Correction to: Oroxylin A promotes PTEN-mediated negative regulation of MDM2 transcription via SIRT3-mediated deacetylation to stabilize p53 and inhibit glycolysis in wt-p53 cancer cells
SIX1 amplification modulates stemness and tumorigenesis in breast cancer
UBR7 inhibits HCC tumorigenesis by targeting Keap1/Nrf2/Bach1/HK2 and glycolysis
Monocytes reprogrammed by tumor microparticle vaccine inhibit tumorigenesis and tumor development
Wip1 and p53 contribute to HTLV-1 Tax-induced tumorigenesis
AKT1 phosphorylation of cytoplasmic ME2 induces a metabolic switch to glycolysis for tumorigenesis
ZFP64 drives glycolysis-mediated stem cell-like properties and tumorigenesis in breast cancer
FKBP4 promotes glycolysis and hepatocellular carcinoma progression via p53/HK2 axis
Oroxylin A promotes PTEN-mediated negative regulation of MDM2 transcription via SIRT3-mediated deacetylation to stabilize p53 and inhibit glycolysis in wt-p53 cancer cells
Skp2 modulates proliferation, senescence and tumorigenesis of glioma
PRMT1-mediated PGK1 arginine methylation promotes colorectal cancer glycolysis and tumorigenesis
The TRPM7 channel reprograms cellular glycolysis to drive tumorigenesis and angiogenesis
Correction to: Oroxylin A promotes PTEN-mediated negative regulation of MDM2 transcription via SIRT3-mediated deacetylation to stabilize p53 and inhibit glycolysis in wt-p53 cancer cells
SIX1 amplification modulates stemness and tumorigenesis in breast cancer
UBR7 inhibits HCC tumorigenesis by targeting Keap1/Nrf2/Bach1/HK2 and glycolysis
Monocytes reprogrammed by tumor microparticle vaccine inhibit tumorigenesis and tumor development
Wip1 and p53 contribute to HTLV-1 Tax-induced tumorigenesis
AKT1 phosphorylation of cytoplasmic ME2 induces a metabolic switch to glycolysis for tumorigenesis
ZFP64 drives glycolysis-mediated stem cell-like properties and tumorigenesis in breast cancer